Leaked data showed that Pfizer’s mevrometostat has strong therapeutic potential in metastatic castration-resistant prostate ...

There are different types of non-Hodgkin’s lymphoma (NHL). Some are fast-growing, while others grow more slowly. Knowing the signs that it’s time to start treatment is important for managing ...

are either B-cell or T-cell types. Only 15% are T-cell lymphomas, while the majority are B-cell lymphomas. Within B-cell lymphoma, there are Hodgkin’s lymphoma and non-Hodgkin’s lymphoma.

Pfizer’s Takeda-partnered blood cancer drug Adcetris (brentuximab vedotin) has been approved by the US Food and Drug ...

Although CAR T-cell therapies have been found effective against certain difficult-to-treat malignancies, they are not devoid of safety concerns.

The FDA has approved a new three-drug combination to treat certain types of an aggressive blood cancer called large B-cell lymphoma (LBCL).